Related Topics News -

     
 Title only   |   Print 
     
《大行》花旗升康哲藥業目標價至16.6元 評級「買入」

2025-08-20T  
《大行》中金升康哲藥業目標價至15.4元 中績略超市場預期

2025-08-20T  
《業績》康哲藥業中期純利9.41億人民幣增3.4% 派息15.55分

2025-08-18T  
康哲藥業改良型新藥ZUNVEYL中國上市許可申請獲受理

2025-07-28T  
《大行》匯豐研究料內地藥企上半年銷售額平均增逾一成 上調多間藥企目標價

2025-07-25T  
康哲藥業於新加坡交易所完成第二上市

2025-07-15T  
康哲藥業創新藥CMS-D001新增適應症獲准開展臨床試驗

2025-07-14T  
康哲藥業預計股份明日新交所開始買賣

2025-07-14T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.